MIV to acquire stroke prevention tech firm SagaX
This article was originally published in Clinica
Executive Summary
Just days after announcing its plan to acquire Indian drug-eluting stent maker Sahajanand Medical Technologies (SMT), Vancouver, Canada-based MIV Therapeutics has signed an agreement to purchase a second firm, SagaX Medical Technologies.